Effectiveness of Copaxone in patients with relapsing-remitting multiple sclerosis
We investigated the effectiveness of Copaxone in patients with relapsing-remitting multiple sclerosis for 3 and 5 years. Significant improvement found the decrease of the frequency of clinical exacerbations and delay the accumulation of physical disability during treatment period.
| Autori principali: | , , |
|---|---|
| Natura: | Articolo |
| Lingua: | English |
| Pubblicazione: |
Siberian State Medical University (Tomsk)
2010-08-01
|
| Serie: | Бюллетень сибирской медицины |
| Soggetti: | |
| Accesso online: | https://bulletin.ssmu.ru/jour/article/view/1618 |